Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 232-242

  Xia, Shengli ^a   Xu, Bianli ^a   Huang, Lili ^a   Zhao, Jia Yong ^a   Ran, Lu ^a   Zhang, Jin ^a   Chen, Haomin ^a   Pulsrikarn, Chaiwat ^b   Pornruangwong, Srirat ^b   Aarestrup, Frank M ^c   Hendriksen, Rene S ^c  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; APRAMYCIN; CEFALOTIN; CEFPODOXIME; CEFTIOFUR; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; FLORFENICOL; GENTAMICIN; NALIDIXIC ACID; NEOMYCIN; SPECTINOMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CHINA; DIARRHEA; FECES CULTURE; FEMALE; GENETIC RESISTANCE; GENETIC SCREENING; GEOGRAPHY; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEASONAL VARIATION; SEROTYPING; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; SPECIES DISTRIBUTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; FECES; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; PREVALENCE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; YOUNG ADULT;

SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA FLEXNERI 2A; SHIGELLA SONNEI;

EID: 78650890044     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01508-10     Document Type: Article

References (32)

1. Andres, P., A. Petroni, D. Faccone, F. Pasteran, R. Melano, M. Rapoport, M. Martinez, C. Culasso, B. A. Di, B. Irigoyen, J. Mulki, A. Procopio, S. M. von, and M. Galas. 2005. Extended-spectrum beta-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int. J. Antimicrob. Agents 25:501-507.
2. Bangtrakulnonth, A., A. R. Vieira, D. M. Lo Fo Wong, S. Pornreongwong, C. Pulsrikarn, P. Sawanpanyalert, R. S. Hendriksen, and F. M. Aarestrup. 2008. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Foodborne. Pathog. Dis. 5:773-784.
3. Bennish, M. L., and B. J. Wojtyniak. 1991. Mortality due to shigellosis: community and hospital data. Rev. Infect. Dis. 13(Suppl. 4):S245-S251.
4. Bopp, C. A., F. W. Brenner, P. I. Fields, J. G. Wells, and N. A. Strockbine. 2003. Escherichia, Shigella, and Salmonella, p. 654-671. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
5. Collignon, P., J. H. Powers, T. M. Chiller, A. Kidara-Kane, and F. M. Aarestrup. 2009. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin. Infect. Dis. 49:132-141.
6. DANMAP. 2008. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods, and humans in Denmark. Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, Copenhagen, Denmark.
7. El-Gendy, A., N. El-Ghorab, E. M. Lane, R. A. Elyazeed, N. I. Carlin, M. M. Mitry, B. A. Kay, S. J. Savarino, and L. F. Peruski, Jr. 1999. Identification of Shigella flexneri subserotype 1c in rural Egypt. J. Clin. Microbiol. 37:873-874.
8. Hendriksen, R. S., A. Bangtrakulnonth, C. Pulsrikarn, S. Pornreongwong, H. Hasman, S. W. Song, and F. M. Aarestrup. 2008. Antimicrobial resistance and molecular epidemiology of Salmonella Rissen from animals, food products, and patients in Thailand and Denmark. Foodborne Pathog. Dis. 5:605-619.
9. Hendriksen, R. S., M. Mikoleit, C. Kornschober, R. L. Rickert, S. V. Duyne, C. Kjelso, H. Hasman, M. Cormican, D. Mevius, J. Threlfall, F. J. Angulo, and F. M. Aarestrup. 2009. Emergence of multidrug-resistant Salmonella concord infections in Europe and the United States in children adopted from Ethiopia, 2003-2007. Pediatr. Infect. Dis. J. 28:814-818.
10. Hu, G. Z., H. Y. Chen, H. B. Si, L. X. Deng, Z. Y. Wei, L. Yuan, and X. H. Kuang. 2008. Phenotypic and molecular characterization of TEM-116 extended-spectrum β-lactamase produced by a Shigella flexneri clinical isolate from chickens. FEMS Microbiol. Lett. 279:162-166.
11. Hu, L. F., J. B. Li, Y. Ye, and X. Li. 2007. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China. J. Microbiol. 45:168-170.
12. Kane, P., and C. Y. Choi. 1999. China's one child family policy. BMJ 319:992-994.
13. Khan, E., K. Jabeen, M. Ejaz, J. Siddiqui, M. F. Shezad, and A. Zafar. Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan. J. Infect. Dev. Countries 3:798-802.
14. Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77:651-666.
15. Kweon, M. N. 2008. Shigellosis: the current status of vaccine development. Curr. Opin. Infect. Dis. 21:313-318.
16. Niyogi, S. K. 2005. Shigellosis. J. Microbiol. 43:133-143.
17. Pryamukhina, N. S., and N. A. Khomenko. 1988. Suggestion to supplement Shigella flexneri classification scheme with the subserovar Shigella flexneri 4c: phenotypic characteristics of strains. J. Clin. Microbiol. 26:1147-1149.
18. Pu, X. Y., J. C. Pan, H. Q. Wang, W. Zhang, Z. C. Huang, and Y. M. Gu. 2009. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J. Antimicrob. Chemother. 63:917-920.
19. Qu, F., Y. L. Mao, E. B. Cui, T. S. Guo, C. M. Bao, L. M. Liu, X. H. Li, and B. Li. 2008. The distribution and antimicrobial resistance tendency of pathogens associated with diarrhea in Beijing. Zhonghua Nei Ke Za Zhi 47:304-307. (In Chinese.)
20. Ribot, E. M., M. A. Fair, R. Gautom, D. N. Cameron, S. B. Hunter, B. Swaminathan, and T. J. Barrett. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne. Pathog. Dis. 3:59-67.
21. Sabra, A. H., G. F. Araj, M. M. Kattar, R. Y. bi-Rached, M. T. Khairallah, J. D. Klena, and G. M. Matar. 2009. Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacillary dysentery in Lebanon. J. Infect. Dev. Countries 3:300-305.
22. Stagg, R. M., P. D. Cam, and N. K. Verma. 2008. Identification of newly recognized serotype 1c as the most prevalent Shigella flexneri serotype in northern rural Vietnam. Epidemiol. Infect. 136:1134-1140.
23. Talukder, K. A., D. K. Dutta, A. Safa, M. Ansaruzzaman, F. Hassan, K. Alam, K. M. Islam, N. I. Carlin, G. B. Nair, and D. A. Sack. 2001. Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. J. Clin. Microbiol. 39:3757-3759.
24. Talukder, K. A., Z. Islam, M. A. Islam, D. K. Dutta, A. Safa, M. Ansaruzzaman, A. S. Faruque, S. N. Shahed, G. B. Nair, and D. A. Sack. 2003. Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated in Bangladesh. J. Clin. Microbiol. 41:110-117.
25. Upton, A., J. Mohiuddin, T. Bathgate, S. Taylor, G. Simmons, R. Woodhouse, and H. Heffernan. 2007. High prevalence of CTX-M-15 extendedspectrum beta-lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15. J. Antimicrob. Chemother. 60:906-908.
26. von, S. L., D. R. Kim, M. Ali, H. Lee, X. Wang, V. D. Thiem, d. G. Canh, W. Chaicumpa, M. D. Agtini, A. Hossain, Z. A. Bhutta, C. Mason, O. Sethabutr, K. Talukder, G. B. Nair, J. L. Deen, K. Kotloff, and J. Clemens. 2006. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 3:e353.
27. Vrints, M., E. Mairiaux, M. E. Van, J. M. Collard, and S. Bertrand. 2009. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J. Clin. Microbiol. 47:1379-1385.
28. Wang, X. Y., F. Tao, D. Xiao, H. Lee, J. Deen, J. Gong, Y. Zhao, W. Zhou, W. Li, B. Shen, Y. Song, J. Ma, Z. M. Li, Z. Wang, P. Y. Su, N. Chang, J. H. Xu, P. Y. Ouyang, S. L. von, Z. Y. Xu, and J. D. Clemens. 2006. Trend and disease burden of bacillary dysentery in China (1991-2000). Bull. World Health Organ. 84:561-568.
29. Xiong, Z., J. Li, T. Li, J. Shen, F. Hu, and M. Wang. 2010. Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China. J. Antibiot. (Tokyo) 63:187-189.
30. Ye, C., R. Lan, S. Xia, J. Zhang, Q. Sun, S. Zhang, H. Jing, L. Wang, Z. Li, Z. Zhou, A. Zhao, Z. Cui, J. Cao, D. Jin, L. Huang, Y. Wang, X. Luo, X. Bai, Y. Wang, P. Wang, Q. Xu, and J. Xu. 2010. Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri. J. Clin. Microbiol. 48:419-426.
31. Yu, H. L., Z. R. Chang, L. S. Zhang, J. Zhang, Z. J. Li, J. G. Xu, and L. Ran. 2007. Analysis on the status of Shigella spp. antimicrobial resistance through data from the National Shigellosis Surveillance System in China, in 2005. Zhonghua Liu Xing Bing Xue Za Zhi 28:370-373. (In Chinese.)
32. Zhang, W., X. Shen, Y. Wang, Y. Chen, M. Huang, Q. Zeng, J. Wei, Q. Lu, G. Wang, L. Deng, X. Wang, K. Yao, S. Yu, and Y. Yang. 2008. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health Pharmacoepidemiol. Drug Safety 17:306-311.